Latest Insider Transactions at Dlh Holdings Corp. (DLHC)
This section provides a real-time view of insider transactions for Dlh Holdings Corp. (DLHC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of DLH Holdings Corp. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of DLH Holdings Corp.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 01
2024
|
Austin J. Yerks Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,941
+6.56%
|
-
|
|
Oct 01
2024
|
Frederick Gerald Wasserman Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,910
+4.65%
|
-
|
|
Oct 01
2024
|
Martin J Delaney Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,941
+35.93%
|
-
|
|
Oct 01
2024
|
Stephen Zelkowicz Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,941
+19.09%
|
-
|
|
Oct 01
2024
|
Frances M Murphy Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,941
+8.99%
|
-
|
|
Oct 01
2024
|
Judith L Bjornaas Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,941
+35.93%
|
-
|
|
Oct 01
2024
|
Elder Granger Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,941
+7.14%
|
-
|
|
Sep 20
2024
|
Kathryn M. John Bull Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
78,240
-13.11%
|
$704,160
$9.78 P/Share
|
|
Sep 20
2024
|
Kathryn M. John Bull Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
200,000
+25.1%
|
$200,000
$1.95 P/Share
|
|
Jul 18
2024
|
Martin J Delaney Director |
BUY
Bona fide gift
|
Indirect |
191,695
+49.16%
|
-
|
|
Jul 18
2024
|
Martin J Delaney Director |
SELL
Bona fide gift
|
Direct |
191,695
-95.72%
|
-
|
|
May 09
2024
|
Martin J Delaney Director |
BUY
Bona fide gift
|
Indirect |
6,544
+49.92%
|
-
|
|
May 09
2024
|
Martin J Delaney Director |
SELL
Bona fide gift
|
Direct |
6,544
-3.16%
|
-
|
|
Feb 20
2024
|
Jeanine M. Christian Pres. Pub. Health & Sci Rs |
SELL
Open market or private sale
|
Direct |
11,985
-100.0%
|
$191,760
$16.21 P/Share
|
|
Feb 16
2024
|
Jeanine M. Christian Pres. Pub. Health & Sci Rs |
SELL
Open market or private sale
|
Direct |
9,027
-42.96%
|
$135,405
$15.92 P/Share
|
|
Feb 15
2024
|
Jeanine M. Christian Pres. Pub. Health & Sci Rs |
SELL
Open market or private sale
|
Direct |
13
-0.06%
|
$208
$16.0 P/Share
|
|
Feb 14
2024
|
Jeanine M. Christian Pres. Pub. Health & Sci Rs |
SELL
Open market or private sale
|
Direct |
100
-0.47%
|
$1,600
$16.75 P/Share
|
|
Feb 13
2024
|
Jeanine M. Christian Pres. Pub. Health & Sci Rs |
SELL
Open market or private sale
|
Direct |
3,826
-15.33%
|
$61,216
$16.99 P/Share
|
|
Jan 19
2024
|
Jeanine M. Christian Pres. Pub. Health & Sci Rs |
SELL
Payment of exercise price or tax liability
|
Direct |
50,049
-66.73%
|
$800,784
$16.29 P/Share
|
|
Jan 19
2024
|
Jeanine M. Christian Pres. Pub. Health & Sci Rs |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+50.0%
|
$600,000
$8.02 P/Share
|
|
Dec 15
2023
|
Galeel Maliek Ferebee Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,764
+50.0%
|
-
|
|
Dec 15
2023
|
Kathryn M. John Bull Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,831
+4.3%
|
-
|
|
Dec 15
2023
|
Zachary Parker CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
58,176
+6.29%
|
-
|
|
Nov 01
2023
|
Zachary Parker CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
39,819
-4.69%
|
$517,647
$13.9 P/Share
|
|
Nov 01
2023
|
Zachary Parker CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+10.55%
|
$100,000
$1.4 P/Share
|
|
Oct 31
2023
|
Kathryn M. John Bull Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
17,785
-4.48%
|
$231,205
$13.68 P/Share
|
|
Oct 31
2023
|
Kathryn M. John Bull Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+15.89%
|
$75,000
$1.4 P/Share
|
|
Oct 01
2023
|
Martin J Delaney Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,569
+3.98%
|
-
|
|
Oct 01
2023
|
Judith L Bjornaas Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,569
+50.0%
|
-
|
|
Oct 01
2023
|
Stephen Zelkowicz Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,569
+19.47%
|
-
|
|
Oct 01
2023
|
Elder Granger Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,569
+6.13%
|
-
|
|
Oct 01
2023
|
Austin J. Yerks Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,569
+5.59%
|
-
|
|
Oct 01
2023
|
Frances M Murphy Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,569
+7.91%
|
-
|
|
Oct 01
2023
|
Frederick Gerald Wasserman Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,111
+3.86%
|
-
|
|
Mar 14
2023
|
Wynnefield Partners Small Cap Value LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
210,000
-7.34%
|
$2,310,000
$11.24 P/Share
|
|
Mar 14
2023
|
Wynnefield Partners Small Cap Value LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
40,000
-3.74%
|
$440,000
$11.24 P/Share
|
|
Feb 28
2023
|
Wynnefield Partners Small Cap Value LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,489
+0.16%
|
$53,868
$12.35 P/Share
|
|
Feb 28
2023
|
Wynnefield Partners Small Cap Value LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
2,053
+0.19%
|
$24,636
$12.35 P/Share
|
|
Jan 27
2023
|
Zachary Parker CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
55,282
+6.88%
|
-
|
|
Nov 01
2022
|
Zachary Parker CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
67,208
-8.84%
|
$873,704
$13.2 P/Share
|
|
Nov 01
2022
|
Zachary Parker CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
250,000
+24.75%
|
$0
$0.95 P/Share
|
|
Oct 01
2022
|
Elder Granger Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,150
+6.23%
|
-
|
|
Oct 01
2022
|
Austin J. Yerks Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,150
+5.64%
|
-
|
|
Oct 01
2022
|
Stephen Zelkowicz Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,150
+23.28%
|
-
|
|
Oct 01
2022
|
Frances M Murphy Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,150
+8.2%
|
-
|
|
Oct 01
2022
|
Frederick Gerald Wasserman Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,617
+3.82%
|
-
|
|
Oct 01
2022
|
Martin J Delaney Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,150
+3.95%
|
-
|
|
Oct 01
2022
|
James P Allen Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,150
+11.02%
|
-
|
|
Sep 13
2022
|
Jacqueline S. Everett Chief Growth Officer |
SELL
Open market or private sale
|
Direct |
1,598
-6.39%
|
$23,970
$15.01 P/Share
|
|
Aug 04
2022
|
Jacqueline S. Everett Chief Growth Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$200,000
$8.02 P/Share
|